136401-69-9

Basic information

• Product Name: 5-[4-[2-(5-Ethyl-2-Pyridyl)Ethoxy]-2-Imino-4-Thiazoldione
• Synonyms: 5-[4-[2-(5-Ethyl-2-Pyridyl)Ethoxy]-2-Imino-4-Thiazoldione;(Z)-5-{4-[2-(5-ETHYLPYRIDIN-2-YL)ETHOXY]BENZYLIDENE}-1,3-THIAZOLIDINE-2,4-DIONE
• CAS NO: 136401-69-9
• Molecular Formula: C₁₉H₁₈N₂O₃S
• Molecular Weight: 354.42
• Mol File: 136401-69-9.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Density: 1.302g/cm³
• Refractive Index: 1.653
• CAS DataBase Reference: 5-[4-[2-(5-Ethyl-2-Pyridyl)Ethoxy]-2-Imino-4-Thiazoldione(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[4-[2-(5-Ethyl-2-Pyridyl)Ethoxy]-2-Imino-4-Thiazoldione(136401-69-9)
• EPA Substance Registry System: 5-[4-[2-(5-Ethyl-2-Pyridyl)Ethoxy]-2-Imino-4-Thiazoldione(136401-69-9)

Safety Data

• Hazardous Substances Data: 136401-69-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C19H18N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,11-12H,2,9-10H2,1H3,(H,21,22,23)/b17-11-

Upstream product

• 136402-00-1 4-[2-(5-ethylpyridin-2-yl)ethoxy] benzonitrile 
• 123-08-0 4-hydroxy-benzaldehyde 
• 1194-02-1 4-fluorobenzonitrile 
• 5223-06-3 5-ethyl-2-(2-hydroxyethyl)pyridine 
• 114393-97-4 4-[2-(5-ethylpyridyl)ethoxy]benzaldehyde 
• 144809-27-8 toluene-4-sulfonic acid 2-(5-ethylpyridin-2-yl)ethyl ester 
• 2295-31-0 thiazoline-2,4-dione 
• 1574532-69-6 Sodium (4-(2-(5-ethylpyridin-2-yl)ethoxy)phenyl)(hydroxy)methanesulfonate 
• 110-89-4 piperidine 

Downstream Products

• 105355-27-9 Pioglitazone 
• 136401-70-2 (E)-5-<4-<2-(5-Ethyl-2-pyridyl)ethoxy>benzylidene>-2,4-thiazolidinedione 

Relevant articles and documents

Reaction pathway of POCl3-mediated Knoevenagel condensation of bisulfite adducts with 2,4-thiazolidinedione

We investigated the POCl3-mediated transformation of aromatic bisulfite adducts to the corresponding 5- arylidenethiazolidine-2,4-diones. The in situ transformation of an aromatic bisulfite adduct to the parent aldehyde in a non-aqueous non-pol

SMALL MOLECULE BCL-XL/BCL-2 BINDING INHIBITORS

Bcl-xL/Bcl-2 binding inhibitors useful in the treatment of unwanted proliferating cells, including cancers and precancers, in subjects in need of such treatment. Also provided are methods of treating a subject having unwanted proliferating cells comprising administering a therapeutically effective amount of a Bcl-xL/Bcl-2 binding inhibitor described herein to a subject in need of such treatment. Also provided are methods of preventing the proliferation of unwanted proliferating cells, such as cancers and precancers, in a subject comprising the step of administering a therapeutically effective amount of Bcl-xL/Bcl-2 binding inhibitor described herein to a subject at risk of developing a condition characterized by unwanted proliferating cells.

Production of benzaldehyde compounds

A method of producing a compound represented by the formula: STR1 wherein R1 stands for hydrogen or an optionally substituted alkyl or acyl group, which comprises reacting a compound represented by the formula: STR2 wherein R1 is of the same meaning as defined above, and R2 stands for an optionally halolgenated alkyl group or an optionally substituted phenyl group with a compound represented by the formula: STR3 in a lower alcohol in the presence of an alkali metal or alkaline earth metal carbonate; the compound (III) being useful as starting compounds for producing thiazolidinedione derivatives having hypoglycemic and hypolipidemic activities.